Prevalence, contributory factors and severity of medication errors associated with direct-acting oral anticoagulants in adult patients: a systematic review and meta-analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1041
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Prevalence, contributory factors and severity of medication errors associated with direct-acting oral anticoagulants in adult patients: a systematic review and meta-analysis ; day:22 ; month:12 ; year:2021 ; pages:1-23
European journal of clinical pharmacology ; (22.12.2021), 1-23
- Creator
-
Rowily, Abdulrhman Al
Jalal, Zahraa
Price, Malcolm J.
Abutaleb, Mohammed H.
Almodiaemgh, Hind
Ammari, Maha Al
Paudyal, Vibhu
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00228-021-03212-y
- URN
-
urn:nbn:de:101:1-2022022617453195026113
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rowily, Abdulrhman Al
- Jalal, Zahraa
- Price, Malcolm J.
- Abutaleb, Mohammed H.
- Almodiaemgh, Hind
- Ammari, Maha Al
- Paudyal, Vibhu
- SpringerLink (Online service)
Other Objects (12)
Medication errors in relation to direct-acting oral anticoagulants: a qualitative study of pharmacists’ views and experiences
Medication errors associated with direct-acting oral anticoagulants: analysis of data from national pharmacovigilance and local incidents reporting databases
Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase®
Direct-Acting Oral Anticoagulants (DOACs) in Cirrhosis and Cirrhosis-Associated Portal Vein Thrombosis
Guideline-discordant dosing of direct-acting oral anticoagulants in the veterans health administration
Switching from warfarin to direct-acting oral anticoagulants: it is time to move forward!
Possible failure of novel direct-acting oral anticoagulants in management of pulmonary embolism: a case report
Use of direct-acting anticoagulants (DOACs) delays surgery and is associated with increased mortality in hip fracture patients
Direct-Acting Oral Anticoagulants in patients at extremes of body weight: a review of pharmacological considerations and clinical implications
Risk–Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational Studies
Efficacy and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in COVID-19 outpatients with cardiometabolic diseases
Direct-acting antivirals and visceral leishmaniasis: a case report
Medication errors in relation to direct-acting oral anticoagulants: a qualitative study of pharmacists’ views and experiences
Medication errors associated with direct-acting oral anticoagulants: analysis of data from national pharmacovigilance and local incidents reporting databases
Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase®
Direct-Acting Oral Anticoagulants (DOACs) in Cirrhosis and Cirrhosis-Associated Portal Vein Thrombosis
Guideline-discordant dosing of direct-acting oral anticoagulants in the veterans health administration
Switching from warfarin to direct-acting oral anticoagulants: it is time to move forward!
Possible failure of novel direct-acting oral anticoagulants in management of pulmonary embolism: a case report
Use of direct-acting anticoagulants (DOACs) delays surgery and is associated with increased mortality in hip fracture patients
Direct-Acting Oral Anticoagulants in patients at extremes of body weight: a review of pharmacological considerations and clinical implications
Risk–Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational Studies
Efficacy and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in COVID-19 outpatients with cardiometabolic diseases
Direct-acting antivirals and visceral leishmaniasis: a case report
Medication errors in relation to direct-acting oral anticoagulants: a qualitative study of pharmacists’ views and experiences
Medication errors associated with direct-acting oral anticoagulants: analysis of data from national pharmacovigilance and local incidents reporting databases
Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase®
Direct-Acting Oral Anticoagulants (DOACs) in Cirrhosis and Cirrhosis-Associated Portal Vein Thrombosis
Guideline-discordant dosing of direct-acting oral anticoagulants in the veterans health administration
Switching from warfarin to direct-acting oral anticoagulants: it is time to move forward!
Possible failure of novel direct-acting oral anticoagulants in management of pulmonary embolism: a case report
Use of direct-acting anticoagulants (DOACs) delays surgery and is associated with increased mortality in hip fracture patients
Direct-Acting Oral Anticoagulants in patients at extremes of body weight: a review of pharmacological considerations and clinical implications
Risk–Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational Studies
Efficacy and safety of direct-acting oral anticoagulants compared to vitamin K antagonists in COVID-19 outpatients with cardiometabolic diseases